VDR and psoriasis: One vitamin D3 analog, calcipotriol (CPT), inhibits cellular DNA and keratin synthesis by binding specifically to the vitamin D receptor (VDR), allowing correction of abnormal keratinocytes proliferation and differentiation (Frieder et al., 2017) is used as a primary topical agent for psoriasis.